ES2170193T3 - Sal que comprende mas de 99,5% en peso de cloruro de sodio y su uso. - Google Patents

Sal que comprende mas de 99,5% en peso de cloruro de sodio y su uso.

Info

Publication number
ES2170193T3
ES2170193T3 ES96200623T ES96200623T ES2170193T3 ES 2170193 T3 ES2170193 T3 ES 2170193T3 ES 96200623 T ES96200623 T ES 96200623T ES 96200623 T ES96200623 T ES 96200623T ES 2170193 T3 ES2170193 T3 ES 2170193T3
Authority
ES
Spain
Prior art keywords
salt
sodium chloride
weight
granules
nacl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96200623T
Other languages
English (en)
Inventor
Leon Ninane
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Solvay SA
Original Assignee
Solvay SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9477467&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2170193(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Solvay SA filed Critical Solvay SA
Application granted granted Critical
Publication of ES2170193T3 publication Critical patent/ES2170193T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01DCOMPOUNDS OF ALKALI METALS, i.e. LITHIUM, SODIUM, POTASSIUM, RUBIDIUM, CAESIUM, OR FRANCIUM
    • C01D3/00Halides of sodium, potassium or alkali metals in general
    • C01D3/26Preventing the absorption of moisture or caking of the crystals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/12Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01DCOMPOUNDS OF ALKALI METALS, i.e. LITHIUM, SODIUM, POTASSIUM, RUBIDIUM, CAESIUM, OR FRANCIUM
    • C01D3/00Halides of sodium, potassium or alkali metals in general
    • C01D3/22Preparation in the form of granules, pieces, or other shaped products
    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01DCOMPOUNDS OF ALKALI METALS, i.e. LITHIUM, SODIUM, POTASSIUM, RUBIDIUM, CAESIUM, OR FRANCIUM
    • C01D3/00Halides of sodium, potassium or alkali metals in general
    • C01D3/22Preparation in the form of granules, pieces, or other shaped products
    • C01D3/24Influencing the crystallisation process

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Seasonings (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Compounds Of Alkaline-Earth Elements, Aluminum Or Rare-Earth Metals (AREA)

Abstract

SAL QUE COMPRENDE MAS DE 99,0% EN PESO DE CLORURO DE SODIO, EN ESTADO DE GRANULOS ESFERICOS DE DIAMETRO MEDIO SUPERIOR A 0,6 MM E INFERIOR A 3 MM Y SU UTILIZACION COMO SAL FARMACEUTICA.
ES96200623T 1995-03-24 1996-03-07 Sal que comprende mas de 99,5% en peso de cloruro de sodio y su uso. Expired - Lifetime ES2170193T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9503588A FR2732004B1 (fr) 1995-03-24 1995-03-24 Sel comprenant du chlorure de sodium et moins de 5% en poids d'eau et son utilisation

Publications (1)

Publication Number Publication Date
ES2170193T3 true ES2170193T3 (es) 2002-08-01

Family

ID=9477467

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96200623T Expired - Lifetime ES2170193T3 (es) 1995-03-24 1996-03-07 Sal que comprende mas de 99,5% en peso de cloruro de sodio y su uso.

Country Status (11)

Country Link
EP (1) EP0733590B1 (es)
JP (1) JPH08259223A (es)
KR (1) KR100424000B1 (es)
AT (1) ATE211118T1 (es)
CA (1) CA2171174A1 (es)
DE (1) DE69618053T2 (es)
DK (1) DK0733590T3 (es)
ES (1) ES2170193T3 (es)
FR (1) FR2732004B1 (es)
NO (1) NO961189L (es)
PT (1) PT733590E (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2821344B1 (fr) * 2001-02-26 2003-04-25 Solvay Granule de substance minerale agglomeree, resistant a l'abrasion, poudre comprenant de tels granules et procede pour sa fabrication
AU2008346088B2 (en) * 2008-01-07 2013-09-19 Council Of Scientific & Industrial Research Free flowing 100 - 500 mm size spherical crystals of common salt and process for preparation thereof
CN107382380A (zh) * 2017-07-27 2017-11-24 蓝德环保科技集团股份有限公司 一种利用草木灰制备生物钾肥的方法
CN107522211B (zh) * 2017-08-18 2019-08-09 天津大学 一种球形氯化钾及其制备方法
CN111302362B (zh) * 2020-04-03 2021-05-07 天津科技大学 一种大颗粒球形盐及其制备方法
CN113999734A (zh) * 2021-10-26 2022-02-01 中盐工程技术研究院有限公司 一种提高软水效能的洗碗机专用盐及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2562884B1 (fr) * 1984-04-16 1988-12-30 Solvay Procede pour la production de sel et sel obtenu par ce procede
JPH01145320A (ja) * 1987-11-30 1989-06-07 Japan Tobacco Inc 8〜14面体結晶食塩製造方法
FR2634665B1 (fr) * 1988-07-29 1991-12-13 Solvay Procede et installation pour la cristallisation d'une substance minerale et cristaux de chlorure de sodium

Also Published As

Publication number Publication date
PT733590E (pt) 2002-06-28
NO961189L (no) 1996-09-25
KR100424000B1 (ko) 2004-06-23
EP0733590A1 (fr) 1996-09-25
DE69618053T2 (de) 2002-09-12
FR2732004B1 (fr) 1997-05-30
NO961189D0 (no) 1996-03-22
CA2171174A1 (fr) 1996-09-25
KR960034075A (ko) 1996-10-22
EP0733590B1 (fr) 2001-12-19
JPH08259223A (ja) 1996-10-08
DE69618053D1 (de) 2002-01-31
FR2732004A1 (fr) 1996-09-27
ATE211118T1 (de) 2002-01-15
DK0733590T3 (da) 2002-04-15

Similar Documents

Publication Publication Date Title
ITRM920489A1 (it) Procedimento per evitare le instabilita' del comportamento su strada di autoveicoli.
HN1997000118A (es) 1,3, oxa thiolane nucleoside compuestos y composiciones
FI935306L (fi) Puhdistettujen, pintaa modifioivien aineiden käyttö estämään hiukkasten kasautumista steriloinnin aikana
FR2678513B1 (fr) Pansement cicatrisant.
FI934051A0 (fi) (s)-(+)-hydroxiklorokin
ES2166379T3 (es) 2-aminotetralinas sustituidas.
DK453589A (da) Biocidsammensaetninger
ATE208607T1 (de) Granuläre zusammenzetzungen
ES2170193T3 (es) Sal que comprende mas de 99,5% en peso de cloruro de sodio y su uso.
IT1232305B (it) Composizione deodorante in granuli sui quali e'adsorbito un profumo od un olio essenziale
NO945070D0 (no) Absorberende hydrogelpartikler i absorpsjonsstrukturer
YU49138B (sh) Proteinski derivat humane lipaze stimulisane žučnom soli
KR880008808A (ko) 비경구투여용 현탁액
YU48310B (sh) Premiks za stočnu hranu
ATE37185T1 (de) Kontrazeptive zusammensetzungen auf basis von levo-norgestrel-estern.
DK0406732T3 (da) Lavviskos, højkoncentreret suspension af overfladeaktivt stof
ES2066902T3 (es) Soluciones estables de analogos de rebecamicina y su preparacion.
DE69202250D1 (de) Photografische hochkontrastelemente,die thioetherverbindungen zur verhinderung von pfefferschleier und zur unterdrückung der ausbreitung des bildes enthalten.
DE69229565D1 (de) Wasserdispergierbare Tablette enthaltend Lamotrigin
RU97122231A (ru) Состав для регулирования разработки нефтяных месторождений
ATE86485T1 (de) Verwendung von aromatischen aminoalkoxyderivaten zur behandlung zerebrovaskulaerer stoerungen.
CO4480101A1 (es) Compuestos ariltios
DE69113675D1 (de) Verwendung von Naproxen als Mydriatikum.
YU25096A (sh) Inhibicija fotodekompozicije 3-supstituisanog-2-oksindola
KR890023982U (ko) 모드 변화에 따른 모니터의 수직크기 조정회로

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 733590

Country of ref document: ES